New York, NY -- (SBWIRE) -- 11/02/2013 -- StockMarketIntel.com issues a special report on the following stocks: Sangamo Biosciences, Inc. (NASDAQ:SGMO), Orexigen Therapeutics, Inc. (NASDAQ:OREX), Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX), The Men's Wearhouse, Inc. (NYSE:MW)
Sangamo Biosciences, Inc. (NASDAQ:SGMO) recently gained 1.18%, while trading on 1.09M shares, at the price of $9.47. The stock changed hands in a range of $9.04 to $9.51 up till now, bringing its market capitalization at about $577.57 million. If we look at its trading history of the past 52 weeks, the share price suffered a low of $4.92 and was moved to the maximum level of $13.20. Sangamo BioSciences, Inc. is a clinical stage biopharmaceutical company. The Company is engaged in the research, development and commercialization of zinc finger deoxyribonucleic acid (DNA)-binding proteins (ZFPs), a naturally occurring class of proteins.
For How Long SGMO will Fight for Profitability? Read This Trend Analysis report
Orexigen Therapeutics, Inc. (NASDAQ:OREX) recently down -0.72% while trading on 1.08M shares, at the price of $4.84. The stock changed hands in a range of $4.83 to $5.04 up till now. If we look at its trading history of the past 52 weeks, the share price suffered a low of $3.91 and was moved to the maximum level of $7.84. Orexigen Therapeutics, Inc. develops drug treatments for obesity and related disorders. Orexigen Therapeutics, Inc. develops and commercializes combinations of currently available drugs that are designed to achieve and sustain weight loss by enhancing satiety, diminishing appetite, improving energy expenditure and minimizing the body's efforts to compensate for weight loss.
Has OREX Found The Bottom And Ready To Gain Momentum? Find Out Here
Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) recently down -1.88% and was moving within a range of $2.33 -$2.42. Its current trading price is $2.36. The share price hit its 52-week low of $1.55 and $3.18 was the best price. The stock completed the day with a total volume of 1.11M shares, versus an average volume of 1.59M shares. Lexicon Pharmaceuticals, Inc. (Lexicon Pharmaceuticals) is a biopharmaceutical company focused on the discovery and development of breakthrough treatments for human disease.
Why Should Investors Buy LXRX After the Recent Fall? Just Go Here and Find Out
The Men's Wearhouse, Inc. (NYSE:MW) added 2.46% in its current trading activity, bringing its market capitalization around $2.07 billion. The total number of shares that changed hands during the current session up till now was 1.02 million shares, as compared to average trading volume of 1.71 million shares. The share price after opening at $42.33 made a high of $43.50 and hovered above $42.15, while its recent trading price was $43.34. The Men?s Wearhouse, Inc., together with its subsidiaries, operates as a specialty apparel retailer in the United States and Canada. It provides suits, suit separates, sport coats, slacks, sportswear, outerwear, dress shirts, shoes, and accessories for men, as well as offers tuxedo rentals.
Why Should Investors Buy MW After The Recent Gain? Just Go Here and Find Out
Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our site, or joining our email list.
Neither StockMarketIntel.com, nor its employees and affiliates are registered as investment advisors or broker/dealers in any jurisdiction whatsoever. Through use of this website viewing or using you agree to hold StockMarketIntel.com, its operators, owners, employees, and affiliates harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources that we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Readers should always do their own due diligence and consult a financial professional. StockMarketIntel.com encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and StockMarketIntel.com makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled company. Any opinions expressed on this website are statements of judgment as of the date of publication and are subject to change without further notice, and may not necessarily be reprinted in future publications or elsewhere.
Read Full disclaimer at: http://stockmarketintel.com/Disclaimer.htm
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)